Clinical Trial Update: Study of GS-1219 in Participants With HIV-1 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating GS-1219 in participants with HIV-1 infection has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GS-1219

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1-infection | Phase 1 | Status: TERMINATED